Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 5 June 2025 - 14:07

Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/2011 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-11-913

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters